Hai Wu

Hai Wu has extensive work experience in the field of biotechnology and research. Hai is currently serving as the CTO of the Antibody Division at ABclonal Technology. Prior to this, they held the position of Vice President at Yurogen Biosystems LLC, where they were responsible for steering research, product development, and manufacturing. Hai also worked as a Postdoctoral Fellow at the University of Vermont, focusing on genome-wide epigenetic control of lineage commitment of bone marrow stem cells and other adult stem cells. Before that, they were a Postdoctoral fellow at UMass Medical School and a Graduate Student at the University of Rochester Medical Center. Overall, Hai Wu has a diverse and extensive background in biotechnology research and development.

Hai Wu has an extensive education history. Hai first attended Wan'An High School, although the specific dates are unknown. After completing high school, they pursued a Bachelor of Science in Biology from Nanchang University, completing their degree between 1993 and 1997. Subsequently, they studied at Fudan University, earning a Master of Science in Human/Medical Genetics from 2000 to 2003. Later, Hai Wu attended the University of Rochester School of Medicine and Dentistry, where they obtained a Doctor of Philosophy (Ph.D.) in Genetics/Medical Genetics between 2003 and 2009.